The results of this study indicate that TRIM21 inhibits GPX4 ubiquitination degradation, increases GPX4 protein stability, inhibits ferroptosis, and promotes the development of mutant p53 colon cancer. The gene discussed is TP53; the disease is malignant colon neoplasm.